These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7129010)

  • 21. In vitro and in vivo cytotoxicity to EL-4 sarcoma in New Zealand mice.
    Gershwin ME; Klingenstein RJ; Chused TM; Steinberg AD
    J Immunol; 1974 Dec; 113(6):1968-77. PubMed ID: 4279264
    [No Abstract]   [Full Text] [Related]  

  • 22. Lectin potentiation of BCG-contact-mediated antitumor action.
    Poduval TB; Seshadri M; Sundaram K
    J Natl Cancer Inst; 1980 Nov; 65(5):909-12. PubMed ID: 6933260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Kinetics of antitumor immunity in experimental brain tumor].
    Aida T; Abe H; Kaneko S; Tsuru M; Kodama T; Kobayashi H
    Neurol Med Chir (Tokyo); 1982 Sep; 22(9):689-95. PubMed ID: 6184627
    [No Abstract]   [Full Text] [Related]  

  • 24. [Anticomplement activity of the serum, ascitic fluid and tumor fluid of animals with transplantable experimental neoplasms. Cytotoxic activity of the antibodies].
    Valguarnera G
    Boll Soc Ital Biol Sper; 1974 Aug; 50(13):1013-6. PubMed ID: 4463978
    [No Abstract]   [Full Text] [Related]  

  • 25. [Immune responsiveness and resistance to bacterial infection in tumor bearing mice].
    Kajiki A
    Fukuoka Igaku Zasshi; 1982 Dec; 73(12):697-710. PubMed ID: 7169207
    [No Abstract]   [Full Text] [Related]  

  • 26. Increased prostaglandin synthesis by macrophages from tumor-bearing mice.
    Pelus LM; Bockman RS
    J Immunol; 1979 Nov; 123(5):2118-25. PubMed ID: 489975
    [No Abstract]   [Full Text] [Related]  

  • 27. In vivo and in vitro studies of the influence of the immune status of C3Hf-Bu mice on the effectiveness of local irradiation of a methylcholanthrene-induced fibrosarcoma.
    Jurin M; Suit HD
    Cancer Res; 1972 Oct; 32(10):2201-11. PubMed ID: 5080765
    [No Abstract]   [Full Text] [Related]  

  • 28. In vitro demonstration of complement-dependent cytotoxic antibodies to Moloney sarcoma cells.
    Tamerius JD; Hellström I
    J Immunol; 1974 Jun; 112(6):1987-96. PubMed ID: 4825783
    [No Abstract]   [Full Text] [Related]  

  • 29. Identification of tumor-associated antigens on ultraviolet light-induced tumors using antitumor antibodies developed in ascites fluid.
    Fortner GW; Takemoto LJ; Shehi L; Hansen JS
    Cancer Res; 1982 Jun; 42(6):2371-4. PubMed ID: 7042083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationships among differentiated T-cell subpopulations. IV. Preferential induction of delayed footpad reaction to xenografts and its radioresistant nature.
    Terasaka R; Nomoto K; Himeno K; Takeya T
    Immunology; 1979 Apr; 36(4):699-705. PubMed ID: 312268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunologic enhancement in a syngeneic tumor system.
    Beltz WR; Levy NL
    Surg Forum; 1975; 26():142-4. PubMed ID: 1216091
    [No Abstract]   [Full Text] [Related]  

  • 32. Facilitation of macrophage-mediated destruction of allogeneic fibrosarcoma cells by tumor-enhancing IgG 2 in vitro.
    Cruse JM; Whitten HD; Lewis GK; Watson ES
    Transplant Proc; 1973 Mar; 5(1):961-7. PubMed ID: 4695960
    [No Abstract]   [Full Text] [Related]  

  • 33. A syngeneic monoclonal antibody to murine Meth-A sarcoma (HepSS-1) recognizes heparan sulfate glycosaminoglycan (HS-GAG): cell density and transformation dependent alteration in cell surface HS-GAG defined by HepSS-1.
    Kure S; Yoshie O
    J Immunol; 1986 Dec; 137(12):3900-8. PubMed ID: 2431047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased sensitivity of murine leukemia virus-infected tumor cells to lymphocyte-mediated cytotoxicity.
    Kasai M; Yamaguchi H; Hosokawa M; Mizushima Y; Kobayashi H
    J Natl Cancer Inst; 1981 Aug; 67(2):417-22. PubMed ID: 6267345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural cytotoxic cells against solid tumors in mice. I. Strain and age distribution and target cell susceptibility.
    Stutman O; Paige CJ; Figarella EF
    J Immunol; 1978 Nov; 121(5):1819-26. PubMed ID: 712067
    [No Abstract]   [Full Text] [Related]  

  • 36. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous tumor growth.
    Takeda K; Smyth MJ; Cretney E; Hayakawa Y; Yamaguchi N; Yagita H; Okumura K
    Cell Immunol; 2001 Dec; 214(2):194-200. PubMed ID: 12088418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of hapten plus antihapten-tumor serum treatment on established rat fibrosarcoma.
    Arai K; Spencer JS; Sohn M; Wallace HW
    Cancer Res; 1979 Jan; 39(1):6-16. PubMed ID: 310708
    [No Abstract]   [Full Text] [Related]  

  • 38. Specific desensitization of resistance against a syngeneic methylcholanthrene-induced sarcoma in C3Hf mice.
    Vaage J
    Cancer Res; 1972 Feb; 32(2):193-9. PubMed ID: 5058179
    [No Abstract]   [Full Text] [Related]  

  • 39. [Antibodies against cells of methylcholanthrene sarcoma in the blood of intact mice].
    Fedorovskaia MI; Vetrova EP; Umanskii IuA
    Biull Eksp Biol Med; 1973 Jul; 76(7):78-80. PubMed ID: 4774443
    [No Abstract]   [Full Text] [Related]  

  • 40. Adoptive immunotherapy of a Gross virus producing lymphoma and a methylcholanthrene-induced fibrosarcoma in tolerant rats.
    Takeichi N; Kuzumaki N; Kodama T; Kobayashi H; Boone CW
    Cancer Res; 1976 Nov; 36(11 Pt 1):4039-43. PubMed ID: 10076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.